Trial record 1 of 2 for:    Abatacept in Adults with Relapsing-remitting Multiple Sclerosis
Previous Study | Return to List | Next Study

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis (ACCLAIM)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Immune Tolerance Network (ITN)
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT01116427
First received: May 3, 2010
Last updated: April 15, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2014
  Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)